OCT 17, 2018 9:00 AM PDT

A comparative study of turnaround times for common hematopathology panels on the Leica Biosystems BOND‑III and the Roche Tissue Diagnostics BenchMark ULTRA instruments.

Sponsored by: Leica Biosystems
Speakers

Abstract
DATE: October 17, 2018
TIME: 09:00am PT, 11:00pm CT, 12:00pm ET
 
Each patient case request can vary in what is required to make a diagnosis by the pathologist.
Many times, the pathologist must order a series of tests with multiple antibodies and slides
grouped into what are commonly called panels. Typically, a pathologist needs to review all slides
from a panel to sign out a report from a patient case. Rapid case reporting is crucial in permitting
clinicians to quickly provide patients with certainty, and to triage them to the most appropriate
therapy.

This study compares the turnaround times of 10 common hematopathology panels for two
leading immunohistochemistry slide staining systems – the Leica Biosystems BOND‑III and the
Roche Tissue Diagnostics BenchMark ULTRA.

Panel turnaround times were measured by the difference between the first slide starting
processing and the last slide completing processing on each instrument. Slide processing
times were analyzed for 24 different antibodies across 10 different hematopathology panels
comprising a total of 88 slides. The instruments were operated at full capacity (up to 30 slides
per instrument) and the panels spread over three separate runs. The testing was performed in
triplicate over three days per platform with a total of 264 slide processed on each instrument.
Ready-to-use antibody protocols were used on each instrument where available.

The study demonstrated that across all 10 panels, the BOND-III had a mean speed advantage of
1.43 hours over the BenchMark ULTRA. Overall, BOND-III had an average panel turnaround
time of 2hr 33m whereas the BenchMark ULTRA had an average panel turnaround time of
3hr 59m.

Show Resources
You May Also Like
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
SEP 13, 2022 8:00 AM PDT
SEP 13, 2022 8:00 AM PDT
Date: September 13, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Preparedness against pandemic diseases demands rapid-response vaccine technology and ready-to-use analytical methods...
OCT 17, 2018 9:00 AM PDT

A comparative study of turnaround times for common hematopathology panels on the Leica Biosystems BOND‑III and the Roche Tissue Diagnostics BenchMark ULTRA instruments.

Sponsored by: Leica Biosystems


Show Resources
Loading Comments...
Show Resources